Logo (Merck) 335 (Belsomra 20 mg)
Generic Name: suvorexant
Pill imprint Logo (Merck) 335 has been identified as Belsomra 20 mg.
Belsomra is used in the treatment of insomnia and belongs to the drug class miscellaneous anxiolytics, sedatives and hypnotics. Risk cannot be ruled out during pregnancy. Belsomra 20 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- suvorexant
- Imprint:
- Logo (Merck) 335
- Strength:
- 20 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous anxiolytics, sedatives and hypnotics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 4 - Some potential for abuse
- Manufacturer:
- Merck, Sharpe & Dohme Corp.
More about Belsomra (suvorexant)
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
